En esta página
HCM HUTCHMED (China) Limited - American Depositary Shares
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Mar 5, 2026
$14,20
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$9,77mínimo 52 semanas
$16,40máximo 52 semanas
Capitalización Bursátil
$12.39B
P/E
27.3
BPA
$0.52
Ingresos
$549M
tus insignias
Rango 52S
$10–$16
Calificación del Analista
BUY
Precio Objetivo
$22
P/E
27.3
ROE
45.7%
Margen de Beneficio Neto
83.3%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
HCM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$14.20
Capitalización Bursátil
$12.39B
P/E
27.3
BPA
$0.52
Ingresos
$549M
ROE
45.7%
Deuda/Capital
0.1
Rango 52S
$10–$16
HCM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$549M2016-12-31 → 2025-12-31
BPA$0.522016-12-31 → 2025-12-31
Flujo de caja libre$-79M2016-12-31 → 2025-12-31
Margen neto83.3%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | HCM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | 27.3promedio 5A ≈72.4 | ≈72.4 | · | · | |
| P/S | 22.6promedio 5A ≈35.0 | ≈35.0 | · | · | |
| P/B (P/C) | 10.0promedio 5A ≈19.8 | ≈19.8 | · | · | |
| EV / EBITDA | -430.8promedio 5A ≈-67.2 | ≈-67.2 | · | · | |
| Price / FCF (Precio / FCF) | -157.2promedio 5A ≈-192.5 | ≈-192.5 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -191.6promedio 5A ≈4993.4 | ≈4993.4 | · | · | |
| EV / Revenue (EV / Ingresos) | 20.3promedio 5A ≈33.3 | ≈33.3 | · | · | |
| EV / FCF | -141.3promedio 5A ≈-180.5 | ≈-180.5 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 10.1promedio 5A ≈19.9 | ≈19.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | HCM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -7.1%promedio 5A ≈-39.9% | ≈-39.9% | · | · | |
| EBITDA Margin (Margen EBITDA) | -4.7%promedio 5A ≈-38.1% | ≈-38.1% | · | · | |
| Pretax Margin (Margen antes de impuestos) | 90.9%promedio 5A ≈-11.8% | ≈-11.8% | · | · | |
| Net Profit Margin (Margen de Beneficio Neto) | 83.3%promedio 5A ≈-7.6% | ≈-7.6% | · | · | |
| ROA | 30.2%promedio 5A ≈-1.3% | ≈-1.3% | · | · | |
| ROE | 45.7%promedio 5A ≈-1.2% | ≈-1.2% | · | · | |
| ROIC | -2.5%promedio 5A ≈-27.5% | ≈-27.5% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | HCM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Debt / Equity (Deuda / Patrimonio) | 0.1promedio 5A ≈0.1 | ≈0.1 | · | · | |
| Current Ratio (Ratio corriente) | 5.0promedio 5A ≈3.4 | ≈3.4 | · | · | |
| Quick Ratio (Ratio Rápido) | 4.7promedio 5A ≈3.1 | ≈3.1 | · | · | |
| Long-Term Debt / Equity (Deuda a Largo Plazo / Patrimonio) | 0.1promedio 5A ≈0.1 | ≈0.1 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | HCM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.4promedio 5A ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover (Rotación de Inventario) | 7.3 | · | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 3.9promedio 5A ≈5.3 | ≈5.3 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$306.4K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
95.6%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2023 | $0.19 | $-0.38 | 149.9% | |
| 31 de diciembre de 2021 | $-0.26 | $-1.06 | 75.6% | |
| 30 de junio de 2021 | $-0.14 | $-0.77 | 81.9% | |
| 31 de diciembre de 2020 | $-0.11 | $-0.44 | 75.2% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | $178M | $87M | |
| Cost of Revenue | $336M | $349M | $384M | $311M | · | · | · | · | $170M | $149M | $105M | $53M | |
| R&D Expense | $148M | $212M | $302M | $387M | $299M | $175M | $138M | $114M | $76M | $67M | $47M | $30M | |
| SG&A Expense | $67M | $64M | $80M | $92M | $89M | $50M | $39M | $31M | $24M | $22M | $20M | $13M | |
| Operating Expenses | $588M | $674M | $820M | $834M | $684M | $425M | $351M | $307M | $295M | $263M | $188M | $106M | |
| Operating Income | $-39M | $-44M | $18M | $-408M | $-328M | $-197M | $-146M | $-93M | $-53M | $-47M | $-10M | $-18M | |
| Interest Expense | · | · | $759.0K | $652.0K | $592.0K | $787.0K | $1M | $1M | $1M | $2M | $1M | $2M | |
| Interest Income | $50M | $40M | $36M | $10M | $2M | $3M | $5M | $6M | $1M | $502.0K | $451.0K | $559.0K | |
| Other Non-op | $61M | $43M | $40M | $-3M | $-9M | $7M | $5M | $6M | $-119.0K | $-659.0K | $-769.0K | $-761.0K | |
| Pretax Income | $499M | $-1M | $58M | $-410M | $-216M | $-190M | $-141M | $-87M | $-54M | $-47M | $-11M | $-3M | |
| Income Tax | $64M | $7M | $5M | $-283.0K | $12M | $5M | $3M | $4M | $3M | $4M | $2M | $1M | |
| Net Income | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | $8M | $-7M | |
| EPS (Basic) | $0.53 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-0.11 | $-0.04 | $0.20 | $-0.64 | $-0.62 | |
| EPS (Diluted) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | $-0.64 | $-0.62 | |
| Shares (Basic) | 858,276,608 | 855,351,683 | 849,654,296 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 664,263,820 | 617,171,710 | 59,715,173 | 54,659,315 | 52,563,387 | |
| Shares (Diluted) | 872,891,120 | 872,829,129 | 869,196,348 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 66,426,382 | 61,717,171 | 59,971,050 | 54,659,315 | 52,563,387 | |
| EBITDA | $-26M | $-31M | $27M | $-399M | $-321M | $-191M | $-141M | $-89M | $-51M | $-44M | · | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $71M | $154M | $284M | $313M | $378M | $236M | $121M | $86M | $85M | $79M | $32M | $39M | |
| Short-term Investments | $1.30B | $682M | $603M | $318M | $634M | $200M | $96M | $215M | $273M | $24M | $0 | · | |
| Receivables | $127M | $156M | $117M | $98M | $84M | $48M | $41M | $40M | $38M | $41M | $33M | · | |
| Inventory | $41M | $50M | $50M | $57M | $36M | $20M | $16M | $12M | $12M | $13M | $10M | · | |
| Prepaid Expense | $8M | $8M | $7M | $22M | $14M | $7M | $4M | $4M | $3M | $699.0K | · | · | |
| Current Assets | $1.57B | $1.07B | $1.10B | $840M | $1.21B | $531M | $317M | $371M | $432M | $167M | $90M | · | |
| PP&E (Net) | $95M | $92M | $100M | $76M | $41M | $24M | $21M | $17M | $14M | $10M | $9M | · | |
| PP&E (Gross) | $168M | $152M | $146M | $113M | $74M | $50M | $44M | $36M | $32M | $24M | $22M | · | |
| Accum. Depreciation | · | · | · | $37M | $33M | $26M | $23M | $20M | $17M | $14M | $13M | $13M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $9M | · | $21.0K | $85.0K | $163.0K | $227.0K | $275.0K | $347.0K | $430.0K | $469.0K | $571.0K | · | |
| Other Non-current Assets | $20M | $12M | $15M | $16M | $22M | $20M | $6M | · | · | · | · | · | |
| Total Assets | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Accounts Payable | $46M | $43M | $36M | $71M | $41M | $32M | $24M | $26M | $24M | $36M | $21M | · | |
| Short-term Debt | $25M | $23M | $31M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $316M | $377M | $403M | $354M | $312M | $158M | $113M | $85M | $105M | $95M | $81M | · | |
| Capital Leases | $2M | $4M | $3M | $5M | $7M | $6M | $3M | · | · | · | · | · | |
| Deferred Tax | $255.0K | $3M | $1M | $3M | $3M | $5M | $3M | · | $4M | $4M | $3M | · | |
| Other Non-current Liabilities | · | $11M | $11M | $12M | $12M | $9M | $6M | $2M | $1M | $8M | $10M | · | |
| Total Liabilities | $502M | $502M | $536M | $393M | $333M | $205M | $152M | $120M | $113M | $138M | $127M | · | |
| Long-term Debt | $93M | $83M | $79M | $18M | · | · | · | $27M | $30M | $47M | $50M | · | |
| Total Debt | $118M | $106M | $110M | $18M | $27M | $27M | $27M | $27M | $30M | $27M | · | · | |
| Common Stock | $87M | $87M | $87M | $86M | $86M | $73M | $67M | $67M | $66M | $61M | $57M | · | |
| Retained Earnings | $-379M | $-833M | $-871M | $-971M | $-610M | $-416M | $-290M | $-183M | $-107M | $-80M | $-92M | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | $2M | $2M | · | |
| AOCI | $-5M | $-12M | $-8M | $-2M | $6M | $4M | $-4M | $-243.0K | $5M | $-4M | $5M | · | |
| Stockholders' Equity | $1.24B | $760M | $731M | $610M | $987M | $484M | $288M | $389M | $462M | $184M | $83M | · | |
| Liabilities + Equity | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Shares Outstanding | 872,328,000 | 871,601,000 | 871,256,000 | 864,775,000 | 864,531,000 | 727,722,000 | 666,906,000 | 666,577,000 | 664,470,000 | 607,058,000 | 56,533,000 | 53,076,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $8M | $9M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Deferred Tax | $-118.0K | $5M | $2M | $-4M | $-5M | $3M | $2M | $2M | $2M | $3M | $1M | · | |
| Other Non-cash | $-596M | $-117M | $179M | $146M | $20M | $84M | $35M | $44M | $-1M | $-24M | · | · | |
| Operating Cash Flow | $-65M | $497.0K | $219M | $-269M | $-204M | $-62M | $-81M | $-33M | $-9M | $-10M | $-9M | $8M | |
| CapEx | $14M | $18M | $33M | $37M | $16M | $8M | $9M | $6M | $5M | $4M | $3M | $4M | |
| Investing Cash Flow | $-29M | $-96M | $-291M | $297M | $-306M | $-125M | $119M | $44M | $-261M | $-34M | $9M | $-15M | |
| Stock Issued | $2M | $790.0K | $5M | $174.0K | $717M | $319M | $251.0K | $4M | $302M | $111M | $1M | $3M | |
| Stock Repurchased | · | $36M | $9M | $48M | $27M | $13M | $346.0K | $5M | $1M | $604.0K | $2M | · | |
| Net Stock Activity | $2M | $-35M | $-4M | $-48M | $690M | $306M | $-95.0K | $-2M | $300M | $110M | · | · | |
| Financing Cash Flow | $8M | $-31M | $49M | $-83M | $650M | $296M | $-1M | $-8M | $273M | $92M | $-5M | $-641.0K | |
| Net Change in Cash | $-83M | $-130M | $-30M | $-64M | $142M | $114M | $35M | $771.0K | $6M | $47M | $-7M | $-8M | |
| Taxes Paid | $62M | $4M | $4M | $19M | $5M | $6M | $3M | $4M | $4M | $3M | $510.0K | $-908.0K | |
| Free Cash Flow | $-79M | $-17M | $187M | $-305M | $-221M | $-70M | $-89M | $-39M | $-14M | $-14M | · | · | |
| Levered FCF | · | · | $186M | $-306M | $-221M | $-71M | $-91M | $-40M | $-16M | $-15M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% | -86.3% | -71.5% | -43.3% | -22.1% | -21.6% | · | · | |
| Net Margin | 83.3% | 6.0% | 12.0% | -84.6% | -54.7% | -55.1% | -51.7% | -34.9% | -11.1% | 5.4% | · | · | |
| Pretax Margin | 90.9% | -0.18% | 7.0% | -96.2% | -60.6% | -83.2% | -68.9% | -40.5% | -22.2% | 9.5% | · | · | |
| EBITDA Margin | -4.7% | -5.0% | 3.2% | -93.6% | -90.2% | -83.6% | -69.0% | -41.6% | -21.1% | -20.5% | · | · | |
| ROA | 30.2% | 2.9% | 8.7% | -30.0% | -18.6% | -21.1% | -21.3% | -13.2% | -5.7% | 4.1% | · | · | |
| ROE | 45.7% | 5.1% | 15.0% | -45.2% | -26.5% | -32.6% | -31.3% | -17.6% | -8.3% | 8.7% | · | · | |
| ROIC | -2.5% | -37.8% | 2.0% | -64.8% | -34.2% | -39.5% | -47.6% | -23.3% | -11.5% | -17.4% | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 | 3.4 | 2.8 | 4.3 | 4.1 | 1.8 | · | · | |
| Quick Ratio | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 | 3.0 | 2.3 | 4.0 | 3.8 | 1.5 | · | · | |
| Debt / Equity | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Interest Coverage | · | · | 24.2 | -625.3 | -554.6 | -249.9 | -142.1 | -91.8 | -36.7 | -28.6 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.5 | 0.7 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.8 | · | · | |
| Inventory Turnover | 7.3 | 6.9 | · | · | · | · | · | · | 13.8 | 13.3 | · | · | |
| Receivables Turnover | 3.9 | 4.6 | 7.8 | 4.7 | 5.4 | 5.2 | 5.0 | 5.4 | 6.1 | 5.8 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.42 | $0.87 | $0.84 | $0.71 | $1.14 | $0.67 | $0.43 | $5.84 | $6.95 | $3.04 | · | · | |
| Revenue / Share | $0.63 | $0.72 | $0.96 | $0.50 | $0.45 | · | · | $3.22 | $3.91 | $3.60 | · | · | |
| Cash Flow / Share | $-0.07 | $0.00 | $0.25 | $-0.32 | $-0.26 | · | · | $-0.49 | $-0.14 | $-0.16 | · | · | |
| Cash / Share | $0.08 | $0.18 | $0.33 | $0.36 | $0.44 | $0.32 | $0.18 | $1.29 | $1.28 | $1.31 | · | · | |
| EPS (TTM) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | · | · | |
| Net Income TTM | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | · | · | |
| Market Cap | $11.63B | $12.56B | $15.78B | $12.78B | $30.33B | $23.30B | $16.72B | $1.54B | $2.62B | $824M | · | · | |
| Enterprise Value | $10.38B | $11.83B | $15.00B | $12.17B | $29.34B | $22.89B | $16.53B | $1.26B | $2.29B | $747M | · | · | |
| P/E | 25.6 | 360.2 | 150.9 | -34.4 | -140.3 | -177.9 | -156.7 | -20.4 | -91.7 | 67.8 | · | · | |
| P/S | 21.2 | 19.9 | 18.8 | 30.0 | 85.2 | 102.2 | 81.6 | 7.2 | 10.9 | 3.8 | · | · | |
| P/B | 9.4 | 16.5 | 21.6 | 20.9 | 30.7 | 48.1 | 58.1 | 4.0 | 5.7 | 4.5 | · | · | |
| P / Tangible Book | 9.5 | 16.6 | 21.7 | 21.1 | 30.8 | 48.5 | · | · | · | · | · | · | |
| P / Cash Flow | -179.8 | 25271.2 | 72.0 | -47.6 | -148.5 | -375.4 | -206.6 | -46.9 | -292.9 | -86.1 | · | · | |
| P / FCF | -147.6 | -720.3 | 84.5 | -41.9 | -137.5 | -332.8 | -186.9 | -39.3 | -187.6 | -59.3 | · | · | |
| EV / EBITDA | -401.5 | -377.2 | 564.4 | -30.5 | -91.4 | -120.1 | -116.9 | -14.2 | -45.1 | -16.8 | · | · | |
| EV / FCF | -131.7 | -678.5 | 80.4 | -39.9 | -133.0 | -327.0 | -184.7 | -32.3 | -164.1 | -53.8 | · | · | |
| EV / Revenue | 18.9 | 18.8 | 17.9 | 28.5 | 82.4 | 100.4 | 80.7 | 5.9 | 9.5 | 3.5 | · | · | |
| Earnings Yield | 3.9% | 0.28% | 0.66% | -2.9% | -0.71% | -0.56% | -0.64% | -4.9% | -1.1% | 1.5% | · | · |
Por Acción
| Métrica | Tendencia | Q4 2019 | Q4 2018 |
|---|---|---|---|
| EPS (TTM) | $-0.16 | $-1.13 |
Valoración (TTM)
| Métrica | Tendencia | Q4 2019 | Q4 2018 |
|---|---|---|---|
| Revenue TTM | $205M | $214M | |
| Net Income TTM | $-106M | $-75M | |
| P/E | -156.7 | -20.4 | |
| Earnings Yield | -0.64% | -4.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $549M | $630M | $838M | $426M | $356M |
| Margen Operativo % | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% |
| Beneficio neto | $457M | $38M | $101M | $-361M | $-195M |
| EPS Diluido | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 |
| Ratio corriente | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 |
| Ratio Rápido | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-79M | $-17M | $187M | $-305M | $-221M |
Propietarios institucionales (13F) 58 declarantes · $45.7M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
58
Valor en tenencia
$45.7M
Nuevas posiciones
9
Posiciones cerradas
4
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 9 (+1 vs trimestre anterior) | 4 (-1 vs trimestre anterior) | 14 (+1 vs trimestre anterior) | 23 (+4 vs trimestre anterior) | +134K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15 823 961 | 1 477 494 | 34,65% | Acciones |
| Allianz Asset Management GmbH | $7 257 739 | 674 511 | 15,89% | Acciones |
| STATE STREET CORP | $3 374 454 | 313 611 | 7,39% | Acciones |
| AIA Group Ltd | $3 133 624 | 291 229 | 6,86% | Acciones |
| M&G PLC | $2 670 701 | 242 791 | 5,85% | Acciones |
| Amundi | $2 199 183 | 204 385 | 4,82% | Acciones |
| JANE STREET GROUP, LLC | $2 092 519 | 194 472 | 4,58% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 400 952 | 130 200 | 3,07% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 123 613 | 104 425 | 2,46% | Acciones |
| XY Capital Ltd | $1 120 439 | 104 130 | 2,45% | Acciones |
| Crossmark Global Holdings, Inc. | $913 685 | 84 915 | 2,00% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $680 548 | 63 248 | 1,49% | Acciones |
| UBS Group AG | $475 409 | 44 183 | 1,04% | Acciones |
| Vanguard Personalized Indexing Management, LLC | $458 365 | 42 599 | 1,00% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $419 285 | 38 967 | 0,92% | Acciones |
| CITADEL ADVISORS LLC | $409 536 | 38 061 | 0,90% | Acciones |
| Vident Advisory, LLC | $286 044 | 26 584 | 0,63% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $284 279 | 26 420 | 0,62% | Acciones |
| StoneX Group Inc. | $213 563 | 18 262 | 0,47% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $195 498 | 18 169 | 0,43% | Acciones |
| AMERIPRISE FINANCIAL INC | $169 384 | 15 742 | 0,37% | Acciones |
| Summit Trail Advisors, LLC | $140 848 | 13 090 | 0,31% | Acciones |
| BANK OF AMERICA CORP /DE/ | $134 382 | 12 489 | 0,29% | Acciones |
| XTX Topco Ltd | $133 521 | 12 409 | 0,29% | Acciones |
| Mariner, LLC | $114 659 | 10 656 | 0,25% | Acciones |
| MORGAN STANLEY | $91 944 | 8 545 | 0,20% | Acciones |
| Blue Trust, Inc. | $82 938 | 7 708 | 0,18% | Acciones |
| ROYAL BANK OF CANADA | $58 000 | 5 428 | 0,13% | Acciones |
| Russell Investments Group, Ltd. | $51 633 | 4 821 | 0,11% | Acciones |
| RHUMBLINE ADVISERS | $41 755 | 3 881 | 0,09% | Acciones |
| FMR LLC | $32 097 | 2 983 | 0,07% | Acciones |
| Rockefeller Capital Management L.P. | $11 632 | 1 081 | 0,03% | Acciones |
| Bell Investment Advisors, Inc | $10 922 | 1 015 | 0,02% | Acciones |
| ASSETMARK, INC | $8 737 | 812 | 0,02% | Acciones |
| BlackRock, Inc. | $7 625 | 709 | 0,02% | Acciones |
| JPMORGAN CHASE & CO | $6 405 | 598 | 0,01% | Acciones |
| Silver Grove Financial Group, Inc. | $6 273 | 583 | 0,01% | Acciones |
| US BANCORP \DE\ | $5 950 | 553 | 0,01% | Acciones |
| Arax Advisory Partners | $4 304 | 400 | 0,01% | Acciones |
| North Star Investment Management Corp. | $4 078 | 379 | 0,01% | Acciones |
| SIMPLEX TRADING, LLC | $3 271 | 304 | 0,01% | Acciones |
| FIDUCIARY FINANCIAL ADVISORS | $3 110 | 291 | 0,01% | Acciones |
| OSAIC HOLDINGS, INC. | $2 485 | 231 | 0,01% | Acciones |
| CITIGROUP INC | $2 055 | 191 | 0,00% | Acciones |
| Physician Wealth Advisors, Inc. | $1 550 | 144 | 0,00% | Acciones |
| Cornerstone Financial Management LLC | $1 442 | 134 | 0,00% | Acciones |
| Pinnacle Wealth Planning Services, Inc. | $1 334 | 124 | 0,00% | Acciones |
| EverSource Wealth Advisors, LLC | $990 | 92 | 0,00% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $696 | 65 166 | 0,00% | Acciones |
| Larson Financial Group LLC | $387 | 36 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| HUTCHMED Group Investment Limited (formerly known as “Hutchison China MediTech Investment Limited”), HUTCHMED (China) Limited | 7 de febrero de 2022 | · | Presentación inicial | · | SEC |
| Hutchison China MediTech Investment Limited, HUTCHMED (China) Limited | 16 de agosto de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
| General Atlantic Singapore HCM Pte. Ltd., General Atlantic Singapore Fund Pte. Ltd., General Atlantic Singapore Interholdco Ltd., General Atlantic Partners (Bermuda) IV, L.P., General Atlantic Partners (Bermuda) EU, L.P., General Atlantic Partners (Lux) SCSp, L.P., General Atlantic GenPar (Lux) SCSp, L.P., General Atlantic (Lux) S.à r.l., General Atlantic GenPar (Bermuda), L.P., GAP (Bermuda) Limited, General Atlantic LLC, GAP Coinvestments III, LLC, GAP Coinvestments IV, LLC, GAP Coinvestments V, LLC, GAP Coinvestments CDA, L.P. ×2 presentaciones | 1 de julio de 2021 | · | Presentación inicial | · | SEC |
| Hutchison Healthcare Holdings Limited, Hutchison Whampoa (China) Limited, CK Hutchison Global Investments Limited, CK Hutchison Holdings Limited ×8 presentaciones | 30 de junio de 2021 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 4 insiders · 4 directivos · 2 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Chig Fung Cheng | Acting CEO and CFO | 20 de mayo de 2026 J | · | 0 | 0 | $0 |
| Wei-Guo Su | CEO and CSO | 20 de mayo de 2026 J | · | 0 | 0 | $0 |
| Lorenso Chiu | Deputy Chief Financial Officer | 20 de mayo de 2026 J | · | 0 | 0 | $0 |
| Charles George Rupert Nixon | Group General Counsel | 20 de mayo de 2026 J | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
HCM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 28 analistas
COMPRA
Objetivo mediano
$19.50
+37,3%
10 35,7%
Compra fuerte
13 46,4%
Compra
5 17,9%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
14 analistas · 2026-10-02Objetivo medio $22.01 +55,0%
Ahora
Precio Actual $14.20
Mín$13.60
Media$22.01
Máx$40.40
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| HCM | $11.63B | 25.6 | · | 83.3% | 45.7% | · |
| RGC | $8.43B | -23.7 | · | · | -54.8% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Intuit (INTU) Launches AI-Native QuickBooks Workforce Platform
Yahoo Finance · 3 meses, 3 semanas atrás
Citi Califica a Cytokinetics, Incorporated (CYTK) como "Máxima Preferencia" entre las Empresas de Biotecnología de Pequeña y Mediana Capitalización
Yahoo Finance · 4 meses atrás
¿Es Paychex, Inc. (PAYX) una buena acción para comprar ahora?
Yahoo Finance · 4 meses, 4 semanas atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 20-F presentada el Mar 5, 2026